New CellAED personal defibrillator technology innovation unveiled at Emergency Services Show 2023
Dr Steven Brooks reveals the innovation behind CellAED®, the world’s first personal, portable defibrillator.
All NHS (National Health Service) broader UK Government and private sector services that rely on NHS Supply Chain for healthcare equipment can access CellAED via framework number ITT_1006.
CellAED is the first significant innovation in automated external defibrillator (AED) technology in more than 30 years
Clinical evidence and engineering data on the world’s first personal defibrillator, CellAED, will receive its international unveiling to the public at this year’s Emergency Services Show.
Dr Steven Brooks, Chief Emergency Physician, Resuscitation Scientist, and Chief Medical Officer at Rapid Response Revival will speak about CellAED, the ground-breaking ultracompact, ultraportable, and cost-effective personal defibrillator, which the UK is one of the first parts of the world to gain access to.
In addition to speaking about how CellAED came to be invented, Dr Brooks will explain the much-anticipated technical innovation behind how CellAED delivers effective shocks with less energy compared to conventional AEDs.
UK emergency services and first responders seeking to understand more about the technological innovation that led to this new category of personal defibrillator will be attending the presentation.
CellAED is the only AED offered under the new NHS Supply Chain category of Personal Defibrillator, created specifically to accommodate CellAED in recognition of the new technology’s unique design and features.
Developed to overcome the challenges of conventional AEDs, CellAED enables improved accessibility and removes a reliance on public access defibrillators. It is addressing the low survival rates of sudden cardiac arrest by driving a change from public to personal AED ownership for the first time.
This creates the potential to bridge the gap in health inequalities and improve survival rates across the UK. Currently, there are more than 30,000 out-of-hospital cardiac arrests in the UK each year, with a survival rate of less than one in 10.1
Designed to be used by minimally trained individuals, the CellAED three-step activation process - Snap Peel Stick™ means it can be applied to someone in seconds. The user will Snap the device to turn on and start voice instructions, Peel to separate the two electrode gel pads, and Stick the pads to the bare chest.
The innovation of CellAED also lies in its ultraportable design, weighing only 450g. This makes it small enough to carry in a handbag or backpack and easily accessible if a sudden cardiac arrest is witnessed.
Dr Steven Brooks, Emergency Physician, Resuscitation Scientist and Chief Medical Officer at Rapid Response Revival said: “Before CellAED, effective response to cardiac arrest relied on proximity to public access defibrillators and the willingness of witnesses to use them. CellAED represents the beginning of an evolution beyond public access to personal access defibrillators. This can and will save lives.
Before now, sudden cardiac arrest survival relied on luck. Technology like CellAED starts to take luck out of the cardiac arrest survival equation, by getting AEDs closer to where most cardiac arrests happen – especially homes.”
CellAED spokesperson Luke Starr added “Most cardiac arrests occur out-of-hospital with up to 80 per cent occurring at home. In the UK, an average of more than 150 people a day die from out of hospital cardiac arrest – that’s one person every ten minutes. This is because for every minute without treatment, chances of survival decrease by 10 per cent. Survival relies on the cardiac arrest being witnessed, the witness’s ability to call emergency services and respond immediately with CPR and defibrillation.
By making CellAED much more affordable than conventional AEDs, we are already starting to see personal defibrillators make their way into UK homes. In a situation where every second counts, CellAED is improving access to life-saving defibrillation, helping to increase the chances of survival from sudden cardiac arrest.”
About CellAED
CellAED was designed to save lives from sudden cardiac arrest (SCA) by making a personal defibrillator that is affordable, accessible, effective, and easy-to-use in the event of an out-of-hospital cardiac arrest.
SCA is a medical emergency that occurs when the heart suddenly stops beating effectively, preventing blood from being pumped around the body. It can happen to anyone, anywhere, at any time. Within seconds, a person in SCA will collapse, become unresponsive, and stop breathing normally. The time critical steps in the treatment of SCA include calling emergency services, starting CPR, and retrieving a defibrillator. For each minute CPR and defibrillation are delayed, the chances of survival decrease by 10 per cent. Every minute counts.
CellAED is designed to empower someone to be prepared to help save a life of someone they care about in the event of witnessing a sudden cardiac arrest.
About Rapid Response Revival®
Rapid Response Revival is a privately-owned start-up company based in Sydney, Australia, established in 2017. Its mission is to save lives from out-of-hospital cardiac arrest.
Rapid Response Revival was established by Donovan Casey, after his partner Sarah experienced a sudden cardiac arrest in their home. With a survival rate of less than 1%, Sarah was lucky to survive.
The Rapid Response Revival flagship product is CellAED, designed to make a personal defibrillator that is affordable, accessible, effective, and easy-to-use in the event of an out-of-hospital cardiac arrest. The world’s first personal AED, CellAED represents the first real improvements on AED technology in more than 30 years.